FOXO3 and malignant colon neoplasm: To test this hypothesis, immunohistochemical staining for two potential miR-182 targets, FOXO1 and FOXO3a, were performed on 10 of the 15 matching tissue sets from SBU CA and AA colon cancer patients (Fig. 3).